Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subcutaneous Injection”

876 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 876 results

Early research (Phase 1)Study completedNCT00931372
What this trial is testing

Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 22
Testing effectiveness (Phase 2)Study completedNCT01450930
What this trial is testing

Pharmacokinetics of Hydrocortisone After Subcutaneous Administration in Chronic Adrenal Insufficiency

Who this might be right for
Primary Adrenal Insufficiency
Bruno Allolio 12
Early research (Phase 1)Study completedNCT01766245
What this trial is testing

A Randomised, Single Centre, Double-blind, Two-period, Cross-over Trial in Healthy Subjects Investigating the Bioequivalence Between Subcutaneous Injections of Semaglutide Produced by Two Manufacturing Processes

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 28
Early research (Phase 1)Study completedNCT02996812
What this trial is testing

Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric Hypoglycemia

Who this might be right for
Hyperinsulinemia Hypoglycemia
Tracey McLaughlin 9
Early research (Phase 1)Study completedNCT04018599
What this trial is testing

Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS

Who this might be right for
Rheumatoid ArthritisPolyarticular Juvenile Idiopathic ArthritisPsoriatic Arthritis+8 more
Fresenius Kabi SwissBioSim GmbH 216
Early research (Phase 1)Study completedNCT03954067
What this trial is testing

An Intratumoral Oncolytic Virus in Patients With Advanced Metastatic Solid Tumors

Who this might be right for
Metastatic CancerSolid TumorsAdvanced Cancer
Astellas Pharma Global Development, Inc. 72
Post-approval studies (Phase 4)Study completedNCT05199571
What this trial is testing

Study of Efficacy and Safety of Ofatumumab in Relapsing Multiple Sclerosis (RMS) Patients in China

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 99
Early research (Phase 1)Study completedNCT01319916
What this trial is testing

Lipid and Adipokine Profiles Following Subcutaneous Injection of ATX-101 Into Abdominal Fat Tissue

Who this might be right for
Healthy
Kythera Biopharmaceuticals 10
Early research (Phase 1)Not Yet RecruitingNCT07489599
What this trial is testing

QLH2405 in Healthy Participants and Participants With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease(AD)Mild Cognitive Impairment (MCI)
Qilu Pharmaceutical Co., Ltd. 68
Testing effectiveness (Phase 2)Study completedNCT00207714
What this trial is testing

An Efficacy and Safety Study of CNTO 148 Subcutaneous Injection Compared With Placebo in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Centocor, Inc. 172
Testing effectiveness (Phase 2)Study completedNCT00733863
What this trial is testing

Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Mild Alzheimer's Patients.

Who this might be right for
Alzheimer Disease
Novartis 27
Testing effectiveness (Phase 2)Study completedNCT04469777
What this trial is testing

Subcutaneous Injection of Erythropoietin on Visual Functions in Patients With Late Onset Optic Neuropathy

Who this might be right for
Optic Neuropathy
Alexandria University 20
Testing effectiveness (Phase 2)Study completedNCT04575467
What this trial is testing

Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 1)

Who this might be right for
Subcutaneous Fat
Caliway Biopharmaceuticals Co., Ltd. 25
Testing effectiveness (Phase 2)Study completedNCT05669014
What this trial is testing

Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM)

Who this might be right for
Idiopathic Inflammatory Myositis
Amgen 12
Early research (Phase 1)Not Yet RecruitingNCT06700083
What this trial is testing

A Safety, Tolerability, Pharmacokinetic Study of SHR-6934 Injection in Healthy Subjects

Who this might be right for
Heart Failure
Beijing Suncadia Pharmaceuticals Co., Ltd 88
Large-scale testing (Phase 3)Study completedNCT00200512
What this trial is testing

Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months

Who this might be right for
Parkinson Disease
Mylan Bertek Pharmaceuticals 16
Large-scale testing (Phase 3)UnknownNCT04733781
What this trial is testing

Subcutaneous Injection of Large Volumes of Tumescent Lidocaine and Epinephrine by Laypersons

Who this might be right for
Venomous SnakebitesLocal AnesthesiaPainless Injection+4 more
Jeffrey Alan Klein, MD 36
Early research (Phase 1)Looking for participantsNCT05318534
What this trial is testing

Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Male and Female Subjects and Safety, Tolerability, Pharmacokinetics, and Pilot Efficacy Biomarkers in Subjects With Cold Agglutinin Disease

Who this might be right for
First in Man Study to Evaluate Initial Safety
Gliknik Inc. 70
Post-approval studies (Phase 4)Study completedNCT03331835
What this trial is testing

A Trial Comparing the Efficacy of Subcutaneous Injections of Brodalumab to Oral Administrations of Fumaric Acid Esters in Adults With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis Vulgaris
LEO Pharma 210
Post-approval studies (Phase 4)Study completedNCT04929093
What this trial is testing

Novel Dose Adjustment Schedule for Late Injection in SCIT in AR

Who this might be right for
Allergic RhinitisImmunotherapy
Beijing Tongren Hospital 102
Load More Results